Serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant).
about
A new humanized in vivo model of KIT D816V+ advanced systemic mastocytosis monitored using a secreted luciferase.Imatinib in systemic mastocytosis: a phase IV clinical trial in patients lacking exon 17 KIT mutations and review of the literature.Highly Aggressive de novo Aleukemic Variant of Mast Cell Leukemia Without KIT D816V Mutation.
P2860
Serum total tryptase level confirms itself as a more reliable marker of mast cells burden in mast cell leukaemia (aleukaemic variant).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum total tryptase level con ...... eukaemia (aleukaemic variant).
@en
Serum total tryptase level con ...... burden in mast cell leukaemia
@nl
type
label
Serum total tryptase level con ...... eukaemia (aleukaemic variant).
@en
Serum total tryptase level con ...... burden in mast cell leukaemia
@nl
prefLabel
Serum total tryptase level con ...... eukaemia (aleukaemic variant).
@en
Serum total tryptase level con ...... burden in mast cell leukaemia
@nl
P2093
P2860
P356
P1476
Serum total tryptase level con ...... leukaemia (aleukaemic variant)
@en
P2093
C De Benedittis
G F Stefanini
G Martinelli
P2860
P304
P356
10.1155/2015/737302
P577
2015-02-10T00:00:00Z